KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Profit After Tax: 2011-2024

Historic Profit After Tax for Sarepta Therapeutics (SRPT) over the last 14 years, with Dec 2024 value amounting to $235.2 million.

  • Sarepta Therapeutics' Profit After Tax fell 7027.37% to -$447.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$248.4 million, marking a year-over-year decrease of 625.17%. This contributed to the annual value of $235.2 million for FY2024, which is 143.89% up from last year.
  • According to the latest figures from FY2024, Sarepta Therapeutics' Profit After Tax is $235.2 million, which was up 143.89% from -$536.0 million recorded in FY2023.
  • Sarepta Therapeutics' Profit After Tax's 5-year high stood at $235.2 million during FY2024, with a 5-year trough of -$703.5 million in FY2022.
  • For the 3-year period, Sarepta Therapeutics' Profit After Tax averaged around -$334.7 million, with its median value being -$536.0 million (2023).
  • In the last 5 years, Sarepta Therapeutics' Profit After Tax slumped by 67.99% in 2022 and then surged by 143.89% in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Profit After Tax (Yearly) stood at -$554.1 million in 2020, then climbed by 24.43% to -$418.8 million in 2021, then slumped by 67.99% to -$703.5 million in 2022, then rose by 23.81% to -$536.0 million in 2023, then spiked by 143.89% to $235.2 million in 2024.